» Articles » PMID: 35986371

Overexpression of NCAPG in Ovarian Cancer is Associated with Ovarian Cancer Proliferation and Apoptosis Via P38 MAPK Signaling Pathway

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Non-SMC condensin I complex subunit G (NCAPG), a member of the subunit of condensin complex, is significantly overexpressed in various cancers and involved in the pathogenesis of cancers. However, the roles of NCAPG in ovarian cancer remain unclear.

Methods: The mRNA expression, overall survival, and disease-free survival of NCAPG in ovarian cancer were analyzed by GEPIA and KM plotter database, and the expression levels of NCAPG in OC tissues and cell lines were determined by qPCR and immunohistochemistry analysis. shRNA targeting NCAPG gene (sh-NCAPG) was utilized to knock down NCAPG expression in OVCAR3 and SKOV3 cells. Subsequently, CCK-8 assay, colony formation assay, transwell invasion assay and flow cytometric analysis were performed to detect the effect of NCAPG on OC cell proliferation, apoptosis, and invasion. Finally, western blot assays were performed to detect the mechanism of NCAPG in ovarian cancer.

Results: Analysis using GEPIA and KM plotter database showed NCAPG was upregulated in ovarian cancer and negatively associated with the survival of OC patients. qPCR and immunohistochemistry analysis confirmed it was highly expressed in both ovarian cancer tissues and cells. The silencing of NCAPG inhibited OC cell proliferation and invasion, and induced cell apoptosis. Additionally, flow cytometric analysis revealed that NCAPG knockdown arrested the cell cycle at G2 and S phases. Furthermore, we also found that downregulation of NCAPG could suppress OC cell proliferation and invasion via activating the p38 MAPK signaling pathway.

Conclusion: Our results suggest that NCAPG exhibits an important role in the development and progression of ovarian cancer and implicates NCAPG as a potential therapeutic target in ovarian cancer.

Citing Articles

CircRNA circACTN4 Promotes the Progression of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Targeting the miR-424-5p/NCAPG/Wnt Axis.

Shan J, Pu J, Chen X, Zhang Y, Li J, Qin L Clin Exp Med. 2025; 25(1):47.

PMID: 39891781 PMC: 11787268. DOI: 10.1007/s10238-025-01573-7.


Association of and genes with milk production traits in Chinese Holstein cows: polymorphism and functional validation analysis.

Wang C, Chen Y, Zhao J, Feng X, Ma R, Wang H Front Vet Sci. 2024; 11:1435128.

PMID: 39545257 PMC: 11561407. DOI: 10.3389/fvets.2024.1435128.


Important role and underlying mechanism of non‑SMC condensin I complex subunit G in tumours (Review).

Li R, Wang D, Yang H, Pu L, Li X, Yang F Oncol Rep. 2024; 51(6).

PMID: 38639175 PMC: 11040534. DOI: 10.3892/or.2024.8736.


Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.

Hou J, Huang P, Xu M, Wang H, Shao Y, Weng X Neuro Oncol. 2023; 25(11):2015-2027.

PMID: 37422706 PMC: 10628937. DOI: 10.1093/neuonc/noad111.


Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer.

Zheng T, Qian T, Zhou H, Cheng Z, Liu G, Huang C Aging (Albany NY). 2023; 15(12):5535-5549.

PMID: 37335105 PMC: 10333058. DOI: 10.18632/aging.204806.


References
1.
Yasui H, Kajiyama H, Tamauchi S, Suzuki S, Peng Y, Yoshikawa N . CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway. Clin Exp Metastasis. 2019; 37(1):145-158. DOI: 10.1007/s10585-019-09993-y. View

2.
Song B, Du J, Song D, Ren J, Feng Y . Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer. Biol Res. 2018; 51(1):44. PMC: 6215350. DOI: 10.1186/s40659-018-0192-5. View

3.
Dong X, Men X, Zhang W, Lei P . Advances in tumor markers of ovarian cancer for early diagnosis. Indian J Cancer. 2015; 51 Suppl 3:e72-6. DOI: 10.4103/0019-509X.154049. View

4.
Xiao C, Gong J, Jie Y, Cao J, Chen Z, Li R . NCAPG Is a Promising Therapeutic Target Across Different Tumor Types. Front Pharmacol. 2020; 11:387. PMC: 7142249. DOI: 10.3389/fphar.2020.00387. View

5.
Jager D, STOCKERT E, Jager E, Gure A, Scanlan M, Knuth A . Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library. Cancer Res. 2000; 60(13):3584-91. View